Loss of ribosomal protein uL14 enables tumor escape from T cell immunosurveillance

Area of Science:

• Immunology
• Cancer Biology
• Molecular Biology

Background:

• CD8+ T cell responses are crucial for anti-tumor immunity and rely on peptide presentation by HLA molecules.
• Antigen processing and presentation (APP) pathways are critical for generating and displaying these peptides.
• Melanoma cells can develop mechanisms to evade immune surveillance.

Purpose of the Study:

• To investigate the role of uL14 in APP and its impact on CD8+ T cell recognition in melanoma.
• To determine how uL14 deficiency affects the characteristics of peptides presented by HLA molecules.
• To assess the functional consequences of altered peptide presentation on melanoma cell killing by CD8+ T cells.

Main Methods:

• Knockdown of uL14 in melanoma cell lines.
• Analysis of peptide characteristics (charge, anchor residues) presented on HLA molecules.
• Prediction of peptide-HLA binding affinity and complex half-life.
• Co-culture assays to evaluate CD8+ T cell-mediated killing of melanoma cells.

Main Results:

• Loss of uL14 significantly downregulated APP components in melanoma cells.
• Peptides generated after uL14 knockdown exhibited altered charge and anchor residue positions.
• These peptides showed reduced predicted binding to HLA alleles and shorter complex half-lives.
• uL14 knockdown led to decreased recognition and killing of melanoma cells by CD8+ T cells.

Conclusions:

• Loss of uL14 alters the peptide repertoire presented by melanoma cells.
• This alteration in peptide presentation may serve as an immune escape mechanism.
• Targeting uL14 could be a potential strategy to enhance anti-tumor immunity in melanoma.